PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-848.38
Negative P/E while Healthcare median is 0.00. Seth Klarman would scrutinize path to profitability versus peers.
No Data
No Data available this quarter, please select a different quarter.
124.39
P/B exceeding 1.5x Healthcare median of 1.64. Jim Chanos would check for potential asset write-down risks.
382.57
P/FCF of 382.57 versus zero FCF in Healthcare. Walter Schloss would verify cash flow quality.
382.57
P/OCF of 382.57 versus zero operating cash flow in Healthcare. Walter Schloss would verify operational quality.
124.39
Fair value ratio exceeding 1.5x Healthcare median of 1.64. Jim Chanos would check for valuation bubble risks.
-0.03%
Negative earnings while Healthcare median yield is 0.00%. Seth Klarman would investigate path to profitability.
0.26%
FCF yield of 0.26% versus zero FCF in Healthcare. Walter Schloss would verify cash flow quality.